Real-option Valuation and Cross-sectional Analysis for Pharmaceutical Companies：Evidence from China Market
With the worldwide impact of Covid-19, more attention has been put on pharmaceutical companies and new drug research and development projects. This research attempts to prove the existence of real option value of pharmaceutical companies in the context of China as the additional value from manageria...
| Main Author: | |
|---|---|
| Format: | Dissertation (University of Nottingham only) |
| Language: | English |
| Published: |
2020
|
| Online Access: | https://eprints.nottingham.ac.uk/61626/ |